Effect	effect	O	O	O	O
of	of	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
maintenance	maintenance	O	O	O	O
therapy	therapy	O	O	O	O
on	on	O	O	O	O
thyroid	thyroid	O	O	O	O
and	and	O	O	O	O
parathyroid	parathyroid	O	O	O	O
function	function	O	O	O	O
.	.	O	O	O	O

OBJECTIVES	objectives	O	O	O	O
:	:	O	O	O	O
To	to	O	O	O	O
assess	assess	O	O	O	O
changes	changes	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
maintenance	maintenance	O	O	O	O
therapy	therapy	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
thyroid	thyroid	O	O	O	O
,	,	O	O	O	O
parathyroid	parathyroid	O	O	O	O
and	and	O	O	O	O
ion	ion	O	O	O	O
alterations	alterations	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
were	were	O	O	O	O
evaluated	evaluated	O	O	O	O
with	with	O	O	O	O
respect	respect	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
duration	duration	O	O	O	O
of	of	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
,	,	O	O	O	O
age	age	O	O	O	O
,	,	O	O	O	O
sex	sex	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
family	family	O	O	O	O
history	history	O	O	O	O
(	(	O	O	O	O
whether	whether	O	O	O	O
or	or	O	O	O	O
not	not	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
had	had	O	O	O	O
a	a	O	O	O	O
first-degree	first-degree	O	O	O	O
relative	relative	O	O	O	O
with	with	O	O	O	O
thyroid	thyroid	O	O	OTHERS	I
disease	disease	O	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

DESIGN	design	O	O	O	O
:	:	O	O	O	O
Prospective	prospective	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

SETTING	setting	O	O	O	O
:	:	O	O	O	O
Affective	affective	O	DISEASE	OTHERS	I
Disorders	disorders	O	DISEASE	OTHERS	I
Clinic	clinic	O	O	O	O
at	at	O	O	O	O
St.	st.	O	O	O	O
Mary	mary	O	O	O	O
's	's	O	O	O	O
Hospital	hospital	O	O	O	O
,	,	O	O	O	O
Montreal	montreal	O	O	O	O
.	.	O	O	O	O

PATIENTS	patients	O	O	O	O
:	:	O	O	O	O
One	one	O	O	O	O
hundred	hundred	O	O	O	O
and	and	O	O	O	O
one	one	O	O	O	O
patients	patients	O	O	O	O
(	(	O	O	O	O
28	28	O	O	O	O
men	men	O	O	O	O
and	and	O	O	O	O
73	73	O	O	O	O
women	women	O	O	O	O
)	)	O	O	O	O
with	with	O	O	O	O
bipolar	bipolar	O	DISEASE	OTHERS	I
disorder	disorder	O	DISEASE	OTHERS	I
receiving	receiving	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
maintenance	maintenance	O	O	O	O
therapy	therapy	O	O	O	O
ranging	ranging	O	O	O	O
from	from	O	O	O	O
1	1	O	O	O	O
year	year	O	O	O	O
's	's	O	O	O	O
to	to	O	O	O	O
32	32	O	O	O	O
years	years	O	O	O	O
'	'	O	O	O	O
duration	duration	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
control	control	O	O	O	O
group	group	O	O	O	O
consisted	consisted	O	O	O	O
of	of	O	O	O	O
82	82	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
no	no	O	O	O	O
psychiatric	psychiatric	O	DISEASE	OTHERS	I
or	or	O	O	O	O
endocrinological	endocrinological	O	O	O	O
diagnoses	diagnoses	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
hospital	hospital	O	O	O	O
's	's	O	O	O	O
out-patient	out-patient	O	O	O	O
clinics	clinics	O	O	O	O
.	.	O	O	O	O

OUTCOME	outcome	O	O	O	O
MEASURES	measures	O	O	O	O
:	:	O	O	O	O
Laboratory	laboratory	O	O	O	O
analyses	analyses	O	O	O	O
of	of	O	O	O	O
calcium	calcium	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
magnesium	magnesium	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
thyroid-stimulating	thyroid-stimulating	O	O	O	O
hormone	hormone	O	O	O	O
levels	levels	O	O	O	O
performed	performed	O	O	O	O
before	before	O	O	O	O
beginning	beginning	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
and	and	O	O	O	O
at	at	O	O	O	O
biannual	biannual	O	O	O	O
follow-up	follow-up	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
Hypothyroidism	hypothyroidism	O	DISEASE	OTHERS	I
developed	developed	O	O	O	O
in	in	O	O	O	O
40	40	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
excluding	excluding	O	O	O	O
8	8	O	O	O	O
patients	patients	O	O	O	O
who	who	O	O	O	O
were	were	O	O	O	O
hypothyroid	hypothyroid	O	DISEASE	OTHERS	I
at	at	O	O	O	O
baseline	baseline	O	O	O	O
.	.	O	O	O	O

All	all	O	O	O	O
patients	patients	O	O	O	O
having	having	O	O	O	O
first-degree	first-degree	O	O	O	O
relatives	relatives	O	O	O	O
affected	affected	O	O	O	O
by	by	O	O	O	O
thyroid	thyroid	O	O	OTHERS	I
illness	illness	O	O	OTHERS	I
had	had	O	O	O	O
accelerated	accelerated	O	O	O	O
onset	onset	O	O	O	O
of	of	O	O	O	O
hypothyroidism	hypothyroidism	O	DISEASE	OTHERS	I
(	(	O	O	O	O
3.7	3.7	O	O	O	O
years	years	O	O	O	O
after	after	O	O	O	O
onset	onset	O	O	O	O
of	of	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
)	)	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
patients	patients	O	O	O	O
without	without	O	O	O	O
a	a	O	O	O	O
family	family	O	O	O	O
history	history	O	O	O	O
(	(	O	O	O	O
8.6	8.6	O	O	O	O
years	years	O	O	O	O
after	after	O	O	O	O
onset	onset	O	O	O	O
of	of	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Women	women	O	O	O	O
over	over	O	O	O	O
60	60	O	O	O	O
years	years	O	O	O	O
of	of	O	O	O	O
age	age	O	O	O	O
were	were	O	O	O	O
more	more	O	O	O	O
often	often	O	O	O	O
affected	affected	O	O	O	O
by	by	O	O	O	O
hypothyroidism	hypothyroidism	O	DISEASE	OTHERS	I
than	than	O	O	O	O
women	women	O	O	O	O
under	under	O	O	O	O
60	60	O	O	O	O
years	years	O	O	O	O
of	of	O	O	O	O
age	age	O	O	O	O
(	(	O	O	O	O
34.6	34.6	O	O	O	O
%	%	O	O	O	O
versus	versus	O	O	O	O
31.9	31.9	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Magnesium	magnesium	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
on	on	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
were	were	O	O	O	O
unchanged	unchanged	O	O	O	O
from	from	O	O	O	O
baseline	baseline	O	O	O	O
levels	levels	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
,	,	O	O	O	O
calcium	calcium	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
were	were	O	O	O	O
higher	higher	O	O	O	O
than	than	O	O	O	O
either	either	O	O	O	O
baseline	baseline	O	O	O	O
levels	levels	O	O	O	O
or	or	O	O	O	O
control	control	O	O	O	O
levels	levels	O	O	O	O
.	.	O	O	O	O

Thus	thus	O	O	O	O
,	,	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
counteracted	counteracted	O	O	O	O
the	the	O	O	O	O
decrease	decrease	O	O	O	O
in	in	O	O	O	O
plasma	plasma	O	O	O	O
calcium	calcium	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
aging	aging	O	O	O	O
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
Familial	familial	O	O	O	O
thyroid	thyroid	O	O	OTHERS	I
illness	illness	O	O	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
risk	risk	O	O	O	O
factor	factor	O	O	O	O
for	for	O	O	O	O
hypothyroidism	hypothyroidism	O	DISEASE	OTHERS	I
and	and	O	O	O	O
hypercalcemia	hypercalcemia	O	DISEASE	OTHERS	I
during	during	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
.	.	O	O	O	O

